Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
473 studies found for:    "Neuroblastoma"
Show Display Options
Download search resultsDownload the search results for:
"Neuroblastoma" (473 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Neuroblastoma Precision Trial
Condition: Neuroblastoma
Intervention: Other: Gene panel sequencing of tumor specimens
2 Terminated
Has Results
Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: Temsirolimus;   Drug: Irinotecan;   Procedure: Surgical Resection of Primary Tumor;   Drug: Cyclophosphamide;   Drug: Doxorubicin;   Drug: Etoposide;   Drug: Cisplatin;   Drug: Topotecan;   Procedure: PBSC;   Radiation: Radiation Therapy;   Drug: 13-cis-retinoic acid
3 Completed Therapy for Children With Advanced Stage High Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: Topotecan, Cyclophosphamide, Cisplatin, Doxorubicin, Etoposide, Ifosfamide, Carboplatin;   Procedure: Peripheral Blood Stem Cell Transplant
4 Completed Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma
Condition: Neuroblastoma
Interventions: Genetic: fluorescence in situ hybridization;   Genetic: gene expression analysis;   Genetic: microarray analysis;   Genetic: mutation analysis;   Genetic: protein analysis;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: microscopy
5 Completed Chemotherapy in Treating Children With Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: buthionine sulfoximine;   Drug: melphalan
6 Completed 131 I-MIBG in Treating Patients With Refractory or Relapsed Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Radiation: iobenguane I 131
7 Completed Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: vincristine sulfate;   Procedure: conventional surgery
8 Completed
Has Results
Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: irinotecan hydrochloride;   Drug: temozolomide
9 Unknown  Surgery in Treating Patients With Neuroblastoma
Condition: Neuroblastoma
Intervention: Procedure: surgical procedure
10 Completed Combination Chemotherapy Followed by Surgery in Treating Infants With Newly Diagnosed Neuroblastoma.
Condition: Neuroblastoma
Interventions: Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: vincristine sulfate;   Procedure: conventional surgery
11 Completed Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: vincristine sulfate
12 Not yet recruiting Immunotherapy of Relapsed Refractory Neuroblastoma With Expanded NK Cells
Condition: Neuroblastoma
Interventions: Drug: Ch14.18;   Biological: NK Cells;   Drug: Lenalidomide
13 Completed
Has Results
hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma
Condition: Neuroblastoma
Intervention: Biological: hu14.18-Interleukin-2 fusion protein
14 Active, not recruiting Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients
Condition: Neuroblastoma
Intervention: Biological: 14g2a.zeta chimeric receptor transduced autologous EBV specific cytotoxic T-lymphocytes (EBV-CTL) w/o lymphodepletion
15 Completed Rebeccamycin Analog in Treating Children With Relapsed or Refractory Neuroblastoma
Condition: Neuroblastoma
Intervention: Drug: becatecarin
16 Completed Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: gene-modified tumor cell vaccine therapy;   Biological: interleukin-2 gene
17 Completed Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: monoclonal antibody 3F8;   Biological: sargramostim
18 Active, not recruiting Surgery in Treating Children With Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Biological: sargramostim;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Radiation: radiation therapy
19 Recruiting Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)
Condition: Neuroblastoma
Intervention: Device: FLT-PET
20 Completed
Has Results
Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide
Condition: Neuroblastoma
Interventions: Drug: DFMO;   Drug: Etoposide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.